Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palliative Primary Tumor Resection in Metastatic Colon Cancer
NCT04416854Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Apr 2020
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in colon cancer, sponsored by Fudan University. Primary endpoint: Overall Survival at 5 years. Started Apr 2020; status: recruiting.
02
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04416854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416854.